Literature DB >> 22868658

Hepatitis: Global eradication of hepatitis B--feasible or fallacy?

Mark Thursz, Ramatoulie Njie, Maud Lemoine.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22868658     DOI： 10.1038/nrgastro.2012.155

Source DB:  PubMed          Journal:  Nat Rev Gastroenterol Hepatol        ISSN： 1759-5045            Impact factor:   46.802


× No keyword cloud information.
  8 in total

1.  Minimization of hepatitis B infection by a 25-year universal vaccination program.

Authors:  Yen-Hsuan Ni; Mei-Hwei Chang; Jia-Feng Wu; Hong-Yuan Hsu; Huey-Ling Chen; Ding-Shinn Chen
Journal:  J Hepatol       Date:  2012-06-02       Impact factor: 25.083

2.  Global epidemiology of hepatitis B virus infection: new estimates of age-specific HBsAg seroprevalence and endemicity.

Authors:  J J Ott; G A Stevens; J Groeger; S T Wiersma
Journal:  Vaccine       Date:  2012-01-24       Impact factor: 3.641

3.  Hepatitis B treatment in resource poor settings: time for action.

Authors:  Mark Thursz; Graham S Cooke; Andrew J Hall
Journal:  Trop Med Int Health       Date:  2009-10-15       Impact factor: 2.622

4.  Epidemiological patterns of hepatitis B virus (HBV) in highly endemic areas.

Authors:  W J Edmunds; G F Medley; D J Nokes; C J O'Callaghan; H C Whittle; A J Hall
Journal:  Epidemiol Infect       Date:  1996-10       Impact factor: 2.451

5.  A mathematical model to estimate global hepatitis B disease burden and vaccination impact.

Authors:  Susan T Goldstein; Fangjun Zhou; Stephen C Hadler; Beth P Bell; Eric E Mast; Harold S Margolis
Journal:  Int J Epidemiol       Date:  2005-10-25       Impact factor: 7.196

6.  Effects of maternal screening and universal immunization to prevent mother-to-infant transmission of HBV.

Authors:  Huey-Ling Chen; Lung-Huang Lin; Fu-Chang Hu; Jian-Te Lee; Wen-Terng Lin; Yao-Jung Yang; Fu-Chen Huang; Shu-Fen Wu; Solomon Chih-Cheng Chen; Wan-Hsin Wen; Chia-Hsiang Chu; Yen-Hsuan Ni; Hong-Yuan Hsu; Pei-Lin Tsai; Cheng-Lun Chiang; Ming-Kwang Shyu; Ping-Ing Lee; Feng-Yee Chang; Mei-Hwei Chang
Journal:  Gastroenterology       Date:  2011-12-23       Impact factor: 22.682

7.  Assessment of cost-effectiveness of universal hepatitis B immunization in a low-income country with intermediate endemicity using a Markov model.

Authors:  Rakesh Aggarwal; Uday C Ghoshal; Subhash R Naik
Journal:  J Hepatol       Date:  2003-02       Impact factor: 25.083

8.  Long-term protection against HBV chronic carriage of Gambian adolescents vaccinated in infancy and immune response in HBV booster trial in adolescence.

Authors:  Marianne A B van der Sande; Pauline A Waight; Maimuna Mendy; Syed Zaman; Steve Kaye; Omar Sam; Abi Kahn; David Jeffries; Aveika A Akum; Andrew J Hall; Ebrima Bah; Samuel J McConkey; Pierre Hainaut; Hilton C Whittle
Journal:  PLoS One       Date:  2007-08-15       Impact factor: 3.240
  8 in total
  9 in total

Review 1.  Prophylactic vaccination against hepatitis B: achievements, challenges and perspectives.

Authors:  Wolfram H Gerlich
Journal:  Med Microbiol Immunol       Date:  2014-12-19       Impact factor: 3.402

Review 2.  Hepatitis B virus: where do we stand and what is the next step for eradication?

Authors:  Haruki Komatsu
Journal:  World J Gastroenterol       Date:  2014-07-21       Impact factor: 5.742

3.  Validation of rapid point-of-care (POC) tests for detection of hepatitis B surface antigen in field and laboratory settings in the Gambia, Western Africa.

Authors:  Harr Freeya Njai; Yusuke Shimakawa; Bakary Sanneh; Lynne Ferguson; Gibril Ndow; Maimuna Mendy; Amina Sow; Gora Lo; Coumba Toure-Kane; Junko Tanaka; Makie Taal; Umberto D'alessandro; Ramou Njie; Mark Thursz; Maud Lemoine
Journal:  J Clin Microbiol       Date:  2015-01-28       Impact factor: 5.948

4.  The gamma-glutamyl transpeptidase to platelet ratio (GPR) predicts significant liver fibrosis and cirrhosis in patients with chronic HBV infection in West Africa.

Authors:  Maud Lemoine; Yusuke Shimakawa; Shevanthi Nayagam; Mustapha Khalil; Penda Suso; Jo Lloyd; Robert Goldin; Harr-Freeya Njai; Gibril Ndow; Makie Taal; Graham Cooke; Umberto D'Alessandro; Muriel Vray; Papa Saliou Mbaye; Ramou Njie; Vincent Mallet; Mark Thursz
Journal:  Gut       Date:  2015-06-24       Impact factor: 23.059

Review 5.  The role of tumour necrosis factor in hepatitis B infection: Jekyll and Hyde.

Authors:  Zina Valaydon; Marc Pellegrini; Alexander Thompson; Paul Desmond; Peter Revill; Gregor Ebert
Journal:  Clin Transl Immunology       Date:  2016-12-09

6.  Hepatitis B: A Current Global Health Dilemma.

Authors:  Jessica Howell; Nimzing G Ladep; Maud Lemoine; Mark R Thursz; Simon D Taylor-Robinson
Journal:  Euroasian J Hepatogastroenterol       Date:  2014-01-22

7.  Substitution rtq267h of hepatitis B virus increases the weight of replication and Lamivudine resistance.

Authors:  Bo Qin; Bo Zhang; Xiaodong Zhang; Tingting He; Wenying Xu; Lijun Fu; Chunyu Tu
Journal:  Hepat Mon       Date:  2013-10-01       Impact factor: 0.660

Review 8.  Comparative analysis of the safety and efficacy of HBsAg-1018 versus HBsAg-Eng: a meta-analysis.

Authors:  Lin L Zhang; Jing Guo; Kai Duan
Journal:  Cent Eur J Immunol       Date:  2020-01-20       Impact factor: 2.085

9.  Viral hepatitis in resource-limited countries and access to antiviral therapies: current and future challenges.

Authors:  Maud Lemoine; Shevanthi Nayagam; Mark Thursz
Journal:  Future Virol       Date:  2013-04       Impact factor: 1.831
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.